The Lancet Regional Health

The Lancet Regional Health – Europe is a new open access journal, part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the European region, with the ultimate goal of improving health outcomes. We aspire to increase the quality of regional and national health research.

The journal publishes high-quality original research that advocates change in, or illuminates, clinical practice and health policy in the European region. We also consider relevant reviews, commentaries, and opinion pieces. The journal invites submissions that are pertaining to regional health topics, including but not limited to prevention and management of infections and non-communicable diseases, improvement of healthy ageing, and reduction of health inequalities.

Article processing charges

No subscription or pay-per-view charges apply to any content published in The Lancet Regional Health – Europe. In order to cover the costs of reviewing, copy editing, layout, and online hosting and archiving, the journal charges an article processing fee of $3500 upon acceptance of submitted research articles (no fee applies to commentaries or opinion pieces).

Authors whose main funder is located either in group A or B countries of the Health Inter Network Access to Research Initiative (HINARI) or in a country with a low UNDP human development index will be exempt from payment. For authors with no formal funding, the country of origin of the majority of authors' institutions will be taken as the source country. If there is no majority country, the corresponding author's country will be so designated.

The editorial decision to accept is taken well before any request is made as to the ability to pay. Payments are processed by a department unconnected to The Lancet Regional Health – Europe's editorial department.

Manuscript guidelines

Manuscript preparation must adhere to relevant reporting standards on the EQUATOR network website. Further details on the different sections of The Lancet Regional Health – Europe, and how to submit to the journal, are provided in the Information for Authors. If you require further clarification, please email your query to [email protected]. Our journal's editorial staff will be pleased to help you.

Wherever possible, figures and good quality photographs should be used to supplement and to enhance the text. We also welcome videos.

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Dr Pooja Jha, Editor-in-Chief
Dr Pooja Jha is the Editor-in-Chief of The Lancet Regional Health – Europe. Prior to this role, she worked at Nature Research as an editor of Nature Metabolism and contributed to the launch of the journal since 2018. Pooja has a BSc degree in Chemistry, Botany, Zoology, and a MSc degree in Medical Molecular Biology and Human Genetics from India. She obtained her PhD in Molecular Medicine at the Medical University of Graz (Austria) where she investigated the role of adipose tissue and liver cross-talk in NAFLD progression. This was followed by her postdoctoral research in computational genetics, mitochondrial supercomplexes, and metabolic diseases at EPFL (Switzerland).

For enquires about The Lancet Regional Health – Europe, contact Pooja Jha at [email protected]

Dr Isabel Hofman, Senior Editor
Dr Isabel Hofman is a Senior Editor for The Lancet Regional Health – Europe. Prior to this role, she worked at Karolinska Institutet (Sweden) as a postdoctoral researcher, focusing on stem cell biology of myelodysplastic syndromes. Isabel earned her BSc and MSc degrees in Biochemistry and Biotechnology at the KU Leuven (Belgium). She then obtained a PhD in Biomedical Sciences at the same university, focusing on the role of ribosomal mutations in cancer.

For enquires about The Lancet Regional Health – Europe, contact Isabel Hofman at [email protected]

Copyright and reuse

All content is published under Creative Commons licensing, which enables authors to retain copyright while allowing others to copy, distribute, and make some uses of their work, provided full credit is given to them as originators. Authors of commercially funded research will be offered a CC BY-NC-ND license. All other authors will be offered a choice of two licences (CC BY or CC BY-NC-ND) depending on whether they wish to allow commercial reuse of their work or whether they wish to allow others to alter their work during its reuse. Authors will be asked to sign an exclusive licence (or non-exclusive licence for government employees) to permit our publisher, Elsevier Ltd, to publish the work in The Lancet Regional Health – Europe.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

Information for Authors

Article processing charges

Manuscript guidelines

About the Editorial team

Copyright and reuse

Ombudsman

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy